Prime Medicine said it has gained FDA clearance for the first human trials of a prime editing therapy as the agency has approved an investigational new drug (IND) application for the company’s first ...

On Friday, the U.S. Food and Drug Administration (FDA) approved a pair of gene therapies for the painful and potentially fatal blood disorder, sickle cell disease (SCD)–including the first-ever CRISPR ...

A nine-month-old baby who was born with a rare genetic disorder is the first person to be successfully treated with personalized CRISPR gene editing therapy, scientists in Philadelphia announced on ...

Months after he became the first infant to undergo gene-editing therapy to treat his rare genetic disorder, 1-year-old KJ Muldoon is accomplishing another first — his first steps. The Children's ...

"I'm ecstatic. It's a blessing that they approved this therapy," said Victoria Gray, the first person in the U.S. to undergo CRISPR gene-editing for sickle cell, of the Food and Drug Administration's ...

SAN FRANCISCO—Prime Medicine is on track to file the first IND/CTA application for human trials of a prime editing therapy to the FDA during the first half of this year, with the first clinical data ...

Rachael has a degree in Zoology from the University of Southampton, and specializes in animal behavior, evolution, palaeontology, and the environment.View full profile Rachael has a degree in Zoology ...

KJ Muldoon, the first infant to undergo gene-editing therapy, has accomplished another first as a 1-year-old — his first steps KJ is walking at home ahead of Christmas after being hospitalized last ...

The FDA approved the genetic therapies for anyone 12 and older suffering from the most severe form of sickle cell disease, a brutal blood disorder that has long been neglected by medical research. The ...

In a landmark decision, the Food and Drug Administration Friday approved the first gene-editing treatment to alleviate human illness. The FDA approved two gene therapies for anyone 12 and older ...